Covestor’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200K | Sell |
1,594
-158
| -9% | -$19.8K | 0.12% | 189 |
|
|
2025
Q1 | $194K | Sell |
1,752
-259
| -13% | -$28.7K | 0.13% | 168 |
|
|
2024
Q4 | $275K | Buy |
2,011
+232
| +13% | +$31.7K | 0.17% | 76 |
|
|
2024
Q3 | $205K | Buy |
1,779
+183
| +11% | +$21.1K | 0.13% | 158 |
|
|
2024
Q2 | $220K | Sell |
1,596
-148
| -8% | -$20.4K | 0.14% | 140 |
|
|
2024
Q1 | $241K | Buy |
1,744
+136
| +8% | +$18.8K | 0.15% | 103 |
|
|
2023
Q4 | $212K | Buy |
1,608
+814
| +103% | +$107K | 0.14% | 116 |
|
|
2023
Q3 | $89K | Sell |
794
-852
| -52% | -$95.5K | 0.07% | 487 |
|
|
2023
Q2 | $155K | Buy |
1,646
+895
| +119% | +$84.3K | 0.12% | 219 |
|
|
2023
Q1 | $76K | Buy |
751
+520
| +225% | +$52.6K | 0.07% | 530 |
|
|
2022
Q4 | $28K | Buy |
231
+108
| +88% | +$13.1K | 0.02% | 937 |
|
|
2022
Q3 | $13K | Hold |
123
| – | – | 0.01% | 1158 |
|
|
2022
Q2 | $12K | Sell |
123
-254
| -67% | -$24.8K | 0.01% | 1138 |
|
|
2022
Q1 | $35K | Buy |
377
+306
| +431% | +$28.4K | 0.02% | 910 |
|
|
2021
Q4 | $6K | Buy |
+71
| New | +$6K | 0.01% | 1238 |
|